IQPC Pharmacovigilance: North American Summit

North American perspectives on a rapidly evolving global landscape

Don’t let the threat of a product recall keep you up at night. Ensure that you and your team are up to date on the latest regulations from the EMA and FDA.

Join us in Boston this October 22-24 at the 2nd Pharmacovigilance North America 2012 as we explore how to develop and maintain a compliant, efficient and low-cost drug safety strategy in order to avoid fines, maximize patient satisfaction and nurture brand loyalty. This event also provides invaluable networking opportunities as well as providing insight into the future of pharmacovigilance.

“This conference is new to Boston!”

Summit topics will include:

A Retrospective on the Evolution of Pharmacovigilance

Good Pharmacovigilance Practice in a Global Environment: Focusing on EMA, FDA & Japanese Regulations

Spontaneous Reporting: Filling the knowledge Gaps

Addressing the Importance of Developing & Implementing a Pre-Marketing Plan

FDA developments and future direction

Designing Post-approval Safety Studies

The Patient Perspective: Gaining & Keeping Customer Trust

Developing & Implementing Strong Post Marketing Best Practices

Linking AE Trends: An Epidemiologist’s Perspective

Shaping an Accurate Risk Profile of Your Drug

Leveraging IT to develop Efficient Operating Models

Know Your Population and Decrease Systemic Errors

Physician training: Spreading the word on proper AE Reporting

Testimonials

"Simple enough to a beginner, complex enough for the experienced. Brilliant" Senior Safety Officer, GSK

"Very interesting with experienced key players" Head of Regional Centre Pharmacovigilance, Boehringer Ingelheim

"Very well organised conference. Attendees mix was nice including industry and regulators! Well done!" Head, Lifesciences EU & APAC, Cognizant

"A great opportunity to network with peers in the region!" Associate Manager, Product Surveillance, Bausch & Lomb

"This conference offers the opportunity for those working in pharmacovigilance to share expertise and learn about best practice and challenge the way they do things" Pharmacovigilance Manager, MSD

"Great opportunity to network with peers in the region!" Associate Manager, Product Surveillance, Bausch & Lomb

"Good forum to discuss Asia Pacific regulations. Good networking. Opportunity to set up a pharmacovigilance working group in this region" Balasubramanian Sankaranarayanan, Head of UFESCIENCES EU & APAC, Cognizant

"The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far". Jean-Christophe Delumeau, Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Center

"Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate pharmacovigilance strategy locally" Aileen Li, Director of Regulatory Affairs, Nycomed China

"Good discussions, good comments from all representatives and speakers" Tay Hui Hui, CPM, EPS International

Learn Best Practices From:

Joanna F Haas MD MSc
Founding Partner
Haas and Partners LLC Ale Vazquez-Gragg
Sr. Director, Global Head of Safety & Pharmacovigilance
RTI International Paul Beninger
Vice President Global Patient Safety and Risk Management
Genzyme Mariette Boerstoel-Streefland, MD, MBA, MS (epi)
Chief Safety Officer, Vice President Global Drug Safety
Forest Research Institute Steve Jolley
Chairperson of the DIA Clinical Safety and Pharmacovigivilance
Steering Committee for North America
DIA

Who should attend?

Senior Vice Presidents, Vice Presidents, Heads, Directors, Specialists, Managers and Leaders of: